by Leland Li | Jan 13, 2025 | Healthcare, Investing News, Market News, Medical Use, Stock Market
orecast, signaling a potentially challenging year ahead. The company now expects revenue for 2025 to fall between $1.5 billion and $2.5 billion, a steep reduction from its previous forecast of $2.5 billion to $3.5 billion issued in September. This adjustment is driven...
by Ming Mui | Jan 18, 2023 | Biotechnology, Healthcare, Investing News, Market News, Personal Finance, Technology, The Market Buzz
Moderna, Inc. (NASDAQ: MRNA) has announced positive data from its ConquerRSV Phase 3 trial of mRNA-1345, an investigational mRNA vaccine that targets respiratory syncytial virus in older adults. Following review by an independent Data and Safety Monitoring Board...
